Clinical Trials Directory

Trials / Completed

CompletedNCT05143762

Preemptive Dexamethasone , Paracetamol on Postoperative Period Following Adeno-tonsillectomy in Pediatric .

Effect of Preemptive Dexamethasone and Paracetamol on Postoperative Period Following Adeno-tosillectomy in Pediatric Age Group-: A Randomized Clinical Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Benha University · Academic / Other
Sex
All
Age
3 Years – 16 Years
Healthy volunteers
Accepted

Summary

Tonsillectomy is one of the most common surgical operations performed on children, and it is frequently linked with an increased risk of complications such as acute discomfort when swallowing and postoperative nausea and vomiting (PONV).The most prevalent causes for postponing discharge home are poorly managed pain and PONV.

Detailed description

Tonsillectomy is one of the most common surgical operations performed on children, and it is frequently linked with an increased risk of complications such as acute discomfort when swallowing and postoperative nausea and vomiting (PONV). The most prevalent causes for postponing discharge home are poorly managed pain and PONV. As a result, these occurrences should be avoided and managed utilizing a multimodal strategy Because of its low cost and adequate safety profile in the treatment of post-tonsillectomy pain, acetaminophen is presently regarded the fundamental analgesic in this situation. Furthermore, acetaminophen has been recommended for use in children, and its pharmacological safety in this age group has been shown. Dexamethasone is another medication that is used to reduce postoperative pain and PONV in various procedures.

Conditions

Interventions

TypeNameDescription
DRUGparacetamolpatients will receive intravenous paracetamol 30mg/kg (max 90 mg/kg/day)
DRUGDexamethasonepatients will receive dexamethasone 0.5mg/kg IV.
DRUGnormal Salinepatients will receive placebo 10 ml normal saline IV.

Timeline

Start date
2021-10-15
Primary completion
2022-03-01
Completion
2022-04-01
First posted
2021-12-03
Last updated
2022-05-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05143762. Inclusion in this directory is not an endorsement.